News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources



6/5/2014 7:56:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Seattle biotech company Kineta keeps adding to its fundraising pool in unexpected ways. The firm announced Thursday it has raised $10 million from a group of companies that also happen to be its drug development partners. Kineta has leaned on nontraditional investors and other funding sources since its 2007 founding. “I wouldn’t say we’ve deliberately steered clear of VCs,” said Kineta president and CEO Chuck Mangess.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES